Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications-Reference-Cited by-同舟云学术

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

Published:2016-02-26 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Bashari Muhammad Hasan,Fan Fengjuan,Vallet Sonia,Sattler Martin,Arn Melissa,Luckner-Minden Claudia,Schulze-Bergkamen Henning,Zörnig Inka,Marme Frederik,Schneeweiss Andreas,Cardone Michael H.,Opferman Joseph T.,Jäger Dirk,Podar Klaus

Funder

DAAD-Indonesian German Scholarship Programme (IGSP)

B. Braun Stiftungs

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0686-4.pdf

Reference63 articles.

1. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–74.

2. Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, et al. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat. 2013;139:539–52.

3. Ellis MJ, Perou CM. The genomic landscape of breast cancer as a therapeutic roadmap. Cancer Discov. 2013;3:27–34.

4. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.

5. Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affinity of PET-MRI Tracers for Hypoxic Cells in Breast Cancer: A Systematic Review;Cells;2024-06-17

2. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment;Frontiers in Immunology;2024-05-10

3. Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications;Breast Cancer Research;2024-04-02

4. Characterization of BCL-XL, MCL-1, and BAX Protein Expression in Response to Neoadjuvant Chemotherapy in Breast Cancer;Applied Immunohistochemistry & Molecular Morphology;2024-03-01

5. Heparanase inhibitor OGT 2115 induces prostate cancer cell apoptosis via the downregulation of MCL‑1;Oncology Letters;2024-01-05